uu.seUppsala University Publications
Change search
ReferencesLink to record
Permanent link

Direct link
Second-line treatment with sulfonylurea compared to DPP4 inhibitors is associated with risk of cardiovascular disease, all-cause mortality and severe hypoglycaemia
Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Clinical diabetology and metabolism.
AstraZeneca, Sodertalje, Sweden..
Karolinska Inst, Stockholm, Sweden.;Karolinska Inst, Stockholm, Sweden..
Karolinska Inst, Stockholm, Sweden..
Show others and affiliations
2015 (English)In: Diabetologia, ISSN 0012-186X, E-ISSN 1432-0428, Vol. 58, no Suppl. 1, S64-S64 p.Article in journal, Meeting abstract (Other academic) Published
Place, publisher, year, edition, pages
2015. Vol. 58, no Suppl. 1, S64-S64 p.
National Category
Endocrinology and Diabetes
URN: urn:nbn:se:uu:diva-264895ISI: 000359820900130OAI: oai:DiVA.org:uu-264895DiVA: diva2:867550
51st Annual Meeting of the European-Association-for-the-Study-of-Diabetes (EASD), SEP 14-18, 2015, Stockholm, SWEDEN

Meeting Abstract: 129

Available from: 2015-11-05 Created: 2015-10-19 Last updated: 2015-11-05Bibliographically approved

Open Access in DiVA

No full text

Search in DiVA

By author/editor
Eriksson, Jan W.
By organisation
Clinical diabetology and metabolism
In the same journal
Endocrinology and Diabetes

Search outside of DiVA

GoogleGoogle Scholar
The number of downloads is the sum of all downloads of full texts. It may include eg previous versions that are now no longer available

Total: 151 hits
ReferencesLink to record
Permanent link

Direct link